Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced new results from the landmark REVERSE trial, evaluating outcomes...
Medtronic plc (NYSE:MDT) today announced financial results for its third quarter of fiscal year 2021, which ended January 29, 2021. The company...
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received approval from the United States Food and Drug...
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the following upcoming investor...
Medtronic plc (NYSE:MDT), the global leader in medical technology, has voluntarily issued a global recall of unused Medtronic Valiant Navion™...
Medtronic plc (NYSE:MDT) announced today that it will report financial results for its third quarter of fiscal year 2021 on Tuesday, February 23,...
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that leading spine surgeons across the U.S. have successfully...
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the results of an independent, prospective observational study...
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced expansion of its limited site release of the recently acquired...
Medtronic plc (NYSE:MDT) has been named to FORTUNE's 2021 World's Most Admired Companies List. The global leader in medical technology landed at #4...
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval...
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the first enrollment in ADAPT-PD (Adaptive DBS Algorithm for...
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the 39th Annual J.P. Morgan...
Medtronic plc (NYSE: MDT) announced that the U.S. Food and Drug Administration (FDA) has cleared the use of navigated interbody and Midas Rex™ high...
Medtronic plc (NYSE: MDT) today announced the release of outcomes in the first 100 patients treated with the OsteoCool™ Radiofrequency Ablation (RFA) ...
Medtronic plc (NYSE:MDT) announced today that Sean Salmon, Executive Vice President and President, Diabetes Operating Unit has been named Executive...
The board of directors of Medtronic plc (NYSE: MDT) on Friday, December 11, 2020, approved the fiscal year 2021 third quarter cash dividend of $0.58...
Medtronic plc (NYSE:MDT) today announced the U.S. commercial launch of the Carpediem™ Cardio-Renal Pediatric Dialysis Emergency Machine. Following...
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the Evercore ISI 3rd Annual...
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the Piper Sandler 32nd Annual...
With the pandemic surging across the globe and food insecurity on the rise, Medtronic and the Medtronic Foundation today announced an additional $3.8 ...
Medtronic plc (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2021, which ended October 30, 2020. The company...
Medtronic plc (NYSE:MDT) announced today that it will report financial results for its second quarter of fiscal year 2021 on Tuesday, November 24,...
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the primary results of the Medtronic-sponsored STOP AF First...
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has completed its friendly tender offer for France-based...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.